Planning Center Inc’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Hold
1,343
0.03% 61
2026
Q1
$292K Buy
1,343
+51
+4% +$11.3K 0.03% 61
2025
Q4
$295K Hold
1,292
0.03% 61
2025
Q3
$299K Sell
1,292
-1
-0.1% -$204 0.03% 61
2025
Q2
$240K Hold
1,293
0.03% 69
2025
Q1
$271K Hold
1,293
0.03% 57
2024
Q4
$230K Hold
1,293
0.03% 62
2024
Q3
$255K Hold
1,293
0.03% 57
2024
Q2
$222K Hold
1,293
0.03% 61
2024
Q1
$235K Buy
+1,293
New +$223K 0.05% 53

Other funds holding ABBV

Planning Center Inc's ABBV Position: Q2 2026 in Review

Planning Center Inc held its AbbVie (ABBV) position steady in Q2 2026 at 1,343 shares worth $338K. The position accounts for 0.03% of the portfolio, ranked #61.

Planning Center Inc first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Planning Center Inc held 1,343 shares of AbbVie worth $338K as of Q2 2026.
  • Planning Center Inc left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.03% of Planning Center Inc's portfolio in Q2 2026, its #61 holding.
  • Planning Center Inc first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Planning Center Inc's 13F filing for Q2 2026, filed 30 Jul 2026.